
How Federal Debts Can Lead To Social Security Garnishments In 2025
Social Security supports millions of Americans, but it isn't completely off-limits. Many recipients assume their benefits are safe once they arrive each month, but that's not always the case.
In some circumstances, the federal government can legally garnish your Social Security payments—especially if you've fallen behind on specific federal debts like taxes or student loans.
Since 2002, more Social Security recipients have become vulnerable to garnishment. Through the Federal Payment Levy Program, the IRS can take up to 15% of monthly benefits to cover unpaid federal taxes, even if that reduces payments below $750.
There's no minimum protection in these cases. Previously, for nontax federal debts like defaulted student loans, the first $750 of monthly benefits was off-limits under the Debt Collection Improvement Act. However, that protection no longer applies to most payments made after 2002, meaning even more of a retiree's check can now be garnished.
If you fall behind on your federal student loans , the government can step in to collect what you owe. It does this through the Treasury Offset Program (TOP), which allows it to take federal payments, including your Social Security checks.
Before 2002, the law used to guarantee that you'd keep at least $750 a month after any garnishment. But now the government can take up to 15% of your Social Security benefits—even if your check is less than $750.
This garnishment doesn't happen right away. It only kicks in if you default and don't work out a repayment plan or rehab your loan. Since Social Security is a lifeline for many retirees, this change means more people could lose a larger portion of their monthly benefits to repay student loans.
Federal law also allows Social Security garnishment for court-ordered payments like child support, alimony or criminal restitution. These garnishments are often higher than the IRS cap—sometimes up to 65% of your benefit, depending on the situation.
If the amount owed is large or if you're already subject to multiple garnishments, such as for taxes and child support, they may see most, or even all, of your benefits withheld.
This is especially important for anyone with unresolved legal obligations. Even if the original case is decades old, the courts can still collect from your Social Security as long as a valid order exists.
Most creditors, like credit card companies or medical debt collectors, cannot directly seize your Social Security benefits. When your benefits are sent straight to your bank account via direct deposit, the law says banks have to protect at least two months' worth of those payments from collection.
But there's a catch. If your Social Security deposits get mixed with other cash in your account, or if your bank can't tell which money came from Social Security, those funds might not be safe from collection attempts. And if you receive your benefits by paper check, you don't have these same protections, leaving you even more exposed.
To keep your benefits safe, make sure your bank knows which deposits are from Social Security and closely monitor your account.
To avoid owing the IRS, filing your tax returns accurately and on time is important. Keeping up with student loan payments and fulfilling child support obligations can also help prevent unexpected collections or garnishments. To easily file your taxes, the best tax filing software inputs your tax forms, identifies possible deductions and provides access to experts when you need assistance.
Social Security doesn't guarantee financial immunity. Falling behind on certain federal or court-mandated debts could shrink your benefits fast, especially if you're not proactive. If you're facing one of these issues, it's better to act early and seek help than to wait for a garnishment notice.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
Dycom Industries (DY) Surged on a Mix of Growth Drivers
Aristotle Capital Boston, LLC, an investment advisor, released its 'Small Cap Equity Strategy' second quarter 2025 investor letter. A copy of the letter can be downloaded here. The second quarter started with a risk-off environment from the previous quarter, but later regained momentum driven by broad-based elements. In the second quarter, the strategy delivered a return of 3.25% net of fees (3.41% gross of fees) underperforming the 8.50% total return of the Russell 2000 Index. For more information on the fund's best picks in 2025, please check its top five holdings. In its second quarter 2025 investor letter, Aristotle Capital Small Cap Equity Strategy highlighted stocks such as Dycom Industries, Inc. (NYSE:DY). Headquartered in Palm Beach Gardens, Florida, Dycom Industries, Inc. (NYSE:DY) provides contracting services to the telecommunications infrastructure and utility industries. The one-month return of Dycom Industries, Inc. (NYSE:DY) was 6.36%, and its shares gained 45.73% of their value over the last 52 weeks. On July 22, 2025, Dycom Industries, Inc. (NYSE:DY) stock closed at $252.68 per share, with a market capitalization of $7.309 billion. Aristotle Capital Small Cap Equity Strategy stated the following regarding Dycom Industries, Inc. (NYSE:DY) in its second quarter 2025 investor letter: "Dycom Industries, Inc. (NYSE:DY), a provider of engineering and construction services to the telecommunications and cable television industries, benefitted from continued growth in its core business, funding tailwinds, and expanding margins as demand for wireline services continues to grow. We maintain our position as we believe the company remains well positioned for longer-term growth alongside secular trends for expanding fiber deployments to support faster broadband connectivity speeds and opportunities to deploy fiber to rural or underserved areas across the country." A 360 degree view of a partially constructed tower, featuring various pieces of equipment and constructionmaterials. Dycom Industries, Inc. (NYSE:DY) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 36 hedge fund portfolios held Dycom Industries, Inc. (NYSE:DY) at the end of the first quarter, which was 37 in the previous quarter. In the fiscal first quarter of 2026, Dycom Industries, Inc. (NYSE:DY) reported $1.259 billion in revenue, reflecting a 10.2% increase over Q1 2025. While we acknowledge the potential of Dycom Industries, Inc. (NYSE:DY) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In another article, we covered Dycom Industries, Inc. (NYSE:DY) and shared best Russell 2000 stocks that have garnered recommendations from Wall Street analysts. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
18 minutes ago
- Yahoo
MasterCard price target lowered to $612 from $640 at Truist
Truist lowered the firm's price target on MasterCard (MA) to $612 from $640 and keeps a Buy rating on the shares. Truist likes the setup for the FinTech sector as earnings results in totality should be solid, and the group has underperformed of late, the analyst tells investors in a research note. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders' Hot Stocks on TipRanks >> Read More on MA: Disclaimer & DisclosureReport an Issue Here's what Wall Street experts are saying about GM and Ford ahead of earnings American Airlines, MasterCard announce extension of partnership Japan Just Found a Way to Earn XRP Without Spending a Yen Starbucks downgraded, Oracle initiated: Wall Street's top analyst calls MasterCard resumed with a Buy at Deutsche Bank Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
18 minutes ago
- Yahoo
Boston Scientific lifts annual profit view on steady heart devices demand
(Reuters) -Boston Scientific raised its annual profit forecast on Wednesday, after strong demand for its heart devices helped the U.S. medical device maker beat second-quarter profit estimates. Shares of the Massachusetts-based company rose 2.3% in premarket trading following the results. A rise in surgical procedures has benefited medical device manufacturers such as Boston Scientific, as it boosted sales and helped offset broader concerns about healthcare spending pressures. Analysts said hospital utilization trends were robust during the second quarter, with hospital checks pointing to high single-digit volume growth - well above the historical average. Boston Scientific's main growth drivers, Farapulse and Watchman, which use short high-voltage pulses to treat certain abnormal heart rhythm conditions, saw strong demand during the quarter. Farapulse, approved in the U.S. to treat certain patients with intermittent atrial fibrillation, competes with Johnson & Johnson's Varipulse and Medtronic's PulseSelect in the market for pulsed field ablation (PFA) systems. "Cardiovascular end-markets remain robust," Truist analyst Richard Newitter said ahead of the earnings, adding that Boston, followed by Medtronic, are in the best position at the moment to benefit from the growing and accelerating PFA market. Rival Johnson & Johnson last week posted strong medtech sales, aided by its heart devices, Varipulse and Trupulse. Boston Scientific expects 2025 adjusted profit of $2.95 to $2.99 per share, up from the prior view of $2.87 to $2.94 earlier. It posted adjusted profit of 75 cents per share for the second quarter, topping analysts' average estimate of 72 cents, according to data compiled by LSEG. The company's cardiovascular unit reported quarterly sales of $3.34 billion, surpassing estimates of $3.20 billion. Revenue came in at $5.06 billion for the quarter, topping estimates of $4.9 billion.